Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.Science Translational Medicine|September 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapyAngela Ianniciello, Martha M Zarou, Kevin M Rattigan, et al.Gynecologic Oncology|January 20, 2020
Hormone receptor expression and outcomes in low-grade serous ovarian carcinomaMarta Llaurado Fernandez, Amy Dawson, Hannah Kim, et al.Journal of Gynecologic Oncology|March 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinomaYuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron, et al.Nature Communications|August 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cellsKevin M Rattigan, Zuzana Brabcova, Daniele Sarnello, et al.NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.Leukemia|September 7, 2018
Targeting quiescent leukemic stem cells using second generation autophagy inhibitorsPablo Baquero, Amy Dawson, Arunima Mukhopadhyay, et al.Cancer Research|January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic VulnerabilityRaunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.Gynecologic Oncology|February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomesStephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.Pageof 3